Adynovate TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: rurioctocog alfa pegol, inert substance
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 250 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 250 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 250 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 250 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 500 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 500 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 1000 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear colourless solution
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1000 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 1000 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear colourless solution
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1000 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 2000 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 2000 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 2000 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 2000 IU pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 1500 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial of drug powder (rurioctocog alfa pegol) and 1 vial of diluent (WFI) with 1 reconstitution system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 1500 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial of drug powder (rurioctocog alfa pegol) and 1 vial of diluent (WFI) with 1 reconstitution system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADYNOVATE rurioctocog alfa pegol (rch) 3000 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White to off-white friable powder
Component :
- Injection, solution
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial of drug powder (rurioctocog alfa pegol) and 1 vial of diluent (WFI) with 1 reconstitution system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems